GTM Manager - Philadelphia
PartifulInternship
Junior (1 to 2 years)
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.
Endocrinology Area Business Manager
In this role, the Endocrinology Area Business Manager (ABM) will develop the territory business plan to achieve/exceed business and sales goals. You will work closely with your team and others across the organization to execute and deliver sales results that contribute to the overall performance, culture, and success of the organization. The Area Business Manager will play a pivotal role in promoting Madrigal and our groundbreaking first-to-market product addressing a significant patient unmet need. As an Area Business Manager, you will be responsible for building relationships with healthcare professionals, driving product adoption, and achieving sales goals within your designated territory. You will work closely with a cross-functional team to educate healthcare providers about the product profile of our innovative therapy.
The Endocrinology Area Business Manager will exhibit exceptionally strong clinical and business acumen. Existing relationships with local Endocrinologist HCPs are strongly preferred, as is working knowledge of market access and local impacts on territory-level business trends. The successful candidate will have an in-depth understanding of analytics to identify business opportunities and create actionable business plans for execution at launch. It is expected that this team member will display a high level of collaboration with cross-functional colleagues to create a positive customer experience for a diverse range of healthcare professionals.
Develops therapies for neurological disorders
Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.